Difference between revisions of "Template:Lipid modifying agents"

From blackwiki
Jump to navigation Jump to search
(Replaced content with '{{Navbox | name = Lipid modifying agents | title = Lipid modifying agents (C10) | groupstyle = backg }}')
imported>ClueBot
m (Reverting possible vandalism by 140.142.221.254 to version by Rudolf Virchow. False positive? Report it. Thanks, ClueBot. (590709) (Bot))
Line 2: Line 2:
 
| name  = Lipid modifying agents
 
| name  = Lipid modifying agents
 
| title = [[Hypolipidemic agent|Lipid modifying agents]] ([[ATC code C10|C10]])
 
| title = [[Hypolipidemic agent|Lipid modifying agents]] ([[ATC code C10|C10]])
| groupstyle = backg
+
| groupstyle = background:MistyRose;
 +
 
 +
| group1 = [[GI tract]]
 +
|  list1 = {{Navbox subgroup
 +
| groupstyle = background:MistyRose;
 +
 
 +
| group1 = [[Cholesterol absorption inhibitor]], [[NPC1L1]]
 +
|  list1 = [[Ezetimibe]]{{•}} [[Sch-48461]]
 +
 
 +
| group2 = [[Bile acid sequestrant|Bile acid sequestrants]]/[[Ion exchange resin|resins]] ([[Low-density lipoprotein|LDL]])
 +
| list2  = [[Cholestyramine|Cholestyramine]]{{•}} [[Colestipol]]{{•}} [[Colestilan]]{{•}} [[Colextran]]{{•}} [[Colesevelam]]
 +
 
 
}}
 
}}
 +
 +
 +
| group2 = [[Liver]]
 +
|  list2 = {{Navbox subgroup
 +
| groupstyle = background:MistyRose;
 +
 +
| group1 = [[Statin]]s ([[HMG-CoA reductase]], [[Low-density lipoprotein|LDL]])
 +
| list1  = [[Atorvastatin]]{{•}} [[Cerivastatin]]<sup>‡</sup>{{•}} [[Fluvastatin]]{{•}} [[Lovastatin]]{{•}} [[Mevastatin]]{{•}} [[Pitavastatin]]{{•}} [[Pravastatin]]{{•}} [[Rosuvastatin]]{{•}} [[Simvastatin]]&nbsp;#
 +
 +
| group2 = Niacin and derivatives ([[High-density lipoprotein|HDL]] and [[Low-density lipoprotein|LDL]])
 +
|  list2 = [[Niceritrol]]{{•}} [[Niacin]]{{•}} [[Nicofuranose]]{{•}} [[Aluminium nicotinate]]{{•}} [[Nicotinyl alcohol]]{{•}} [[Acipimox]]
 +
 +
}}
 +
 +
| group4 = [[Blood vessel]]s
 +
|  list4 = {{Navbox subgroup
 +
| groupstyle = background:MistyRose;
 +
 +
| group1 =  [[Fibrate]]s ([[PPAR modulator|PPAR]])
 +
| list1  = [[Clofibrate]]<sup>‡</sup>{{•}} [[Bezafibrate]]{{•}} [[Aluminium clofibrate]]{{•}} [[Gemfibrozil]]{{•}} [[Fenofibrate]]{{•}} [[Simfibrate]]{{•}} [[Ronifibrate]]{{•}} [[Ciprofibrate]]{{•}} [[Etofibrate]]{{•}} [[Clofibride]]{{•}} [[Clinofibrate]]
 +
 +
 +
| group2 = [[CETP inhibitor]]s ([[High-density lipoprotein|HDL]])
 +
|  list2 = [[Anacetrapib]]<sup>†</sup>{{•}} [[Torcetrapib]]<sup>§</sup>{{•}} [[JTT-705]]
 +
 +
 +
 +
}}
 +
 +
 +
| group7 = Combinations
 +
|  list7 = [[Niacin/lovastatin]]{{•}} [[Niacin/simvastatin]]{{•}} [[Ezetimibe/simvastatin]]
 +
 +
| group8 = Other
 +
|  list8 = [[Dextrothyroxine]]{{•}} [[Probucol]]{{•}} [[Tiadenol]]{{•}} [[Benfluorex]]{{•}} [[Meglutol]]{{•}} [[Omega-3-triglycerides]]{{•}} [[Magnesium pyridoxal 5-phosphate glutamate]]{{•}} [[Policosanol]]{{•}} [[Lapaquistat]]<sup>§</sup>{{•}} [[Alipogene tiparvovec]]
 +
 +
| list9 = <sup>†</sup>Undergoing [[clinical trial]]s.&nbsp;<sup>‡</sup>[[List of withdrawn drugs|Withdrawn]] from market.&nbsp;<sup>§</sup>[[Drug development|Development]] terminated. # = [[List of World Health Organization Essential Medicines|WHO-EM]]
 +
}}<noinclude>
 +
 +
[[Category:Drug templates|{{PAGENAME}}]]
 +
</noinclude>

Revision as of 00:14, 19 February 2009